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Abstract  
Cytokines are potentially useful biomarkers of sepsis and other inflammatory conditions. Many cytokines can be released by leukocytes and platelets after 
sampling. The sampling and processing techniques are consequently critically important to measure the in vivo levels. We therefore examined the effects of 
four different anticoagulants, lepirudin, heparin, citrate and EDTA, compared to serum, on the levels of 27 different cytokines. The effects of storage 
temperature, freezing and thawing on the plasma cytokines were examined. Cytokines were analysed using a multiplex immunoassay. The cytokine levels in 
serum were significantly higher compared with plasma, consistent with release of cytokines in vitro during coagulation.  In general, the lowest values for all 
cytokines were found in EDTA samples, stored on crushed ice, centrifuged within 4 h and thereafter store at -80°C. MCP-1 and MIP-1β levels were highest in 
heparin plasma and storage for up to 4 h at room temperature significantly increased the IL-2, IL-6, IL-8, IFN-γ and GM-CSF levels in EDTA plasma, 
indicating post-sampling release.  In contrast, the IL-10 and IP-10 levels in EDTA plasma were unaffected by sample storage at both temperatures. Our results 
indicate that the cytokines were more stable in plasma than in whole blood after sampling. Thus, cytokines should be analysed in EDTA plasma samples stored 
on ice and centrifuged within 4 h. Based on these data, the reference ranges of 27 cytokines in EDTA plasma in 162 healthy human donors were calculated.  
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1. Introduction 
Cytokines, chemokines and growth factors are potential biomarkers of sepsis and other inflammatory diseases [1-3]. These compounds are extensively used as 
biomarkers of inflammation in a number of human diseases and inflammatory conditions [4-10]. In the case of many analytes in general, much attention has 
been focussed on the preanalytical sampling conditions [11, 11-13]. Although poorly studied, the sampling and processing techniques used for analysis of the 
cytokine levels in plasma and/or serum samples might also be important. To obtain cytokine values representative of the in vivo conditions, the sampling 
techniques must prevent cytokines from being released by blood leukocytes after sampling. The time and the storage temperature between the sampling and 
centrifugation steps might therefore be important.  
 
Human blood leukocytes, including monocyte-macrophages and neutrophils, synthesize a number of cytokines after stimulation with an endotoxin or bacteria 
through Toll-like receptor activation [14]. A number of other stimuli, including bacterial products [15], complement fragment C5a [16], immune complexes, 
complement activation, C5a [17] and calcium ionophores also stimulate cytokine synthesis [18]. Coagulation activation itself and thrombin can also enhance 
the release of IL-1β, IL-6 and TNF by monocytes through activation of protease-activated receptors [19]. Thrombin can activate protease-activated receptor 
(PAR)-1 and PAR-4, leading to leukocyte activation and cytokine release [19].  
 
When blood is drawn into plastic tubes, complement and coagulation activation by the plastic surface leads to the activation of immune-competent cells and 
platelets, in part due to their recognition of this foreign surface [20]. This phenomenon of activation by foreign surfaces is termed bioincompatibility and 
opposite biocompatibility [20]. Complement is rapidly activated by plastic and other foreign surfaces and participates in the activation of platelets and 
leukocytes [21]. Coating plastic tubing with heparin effectively reduces complement activation and cytokine release [22]. The release of the anaphylatoxin C5a 
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is involved in cytokine release triggered by several different stimuli [17, 23]. In addition, coagulation activation and thrombin can also stimulate immune-
competent cells, including leukocytes, leading to cytokine release [24].  
 
Previously, most studies used serum for cytokine measurements [25]. The manufacturer of many ELISA and immunoassay kits for cytokine analyses also 
recommends using serum samples for the analyses. However, several studies indicated that coagulation activation is linked to inflammation in a process called 
immunothrombosis [26]. The potential role of thrombin in coagulation activation leading to cytokine release in human whole blood samples is yet to be 
examined. Several anticoagulants, such as EDTA and citrate, bind calcium and thereby inhibit both coagulation and the activation of the complement system. 
However, newer anticoagulants, such as hirudin and its recombinant analogue lepirudin, which specifically inhibit thrombin, have not been evaluated as 
anticoagulants for use in cytokine analyses. In contrast to heparin and calcium-binding anticoagulants, such as EDTA and citrate, lepirudin has no adverse 
effects on complement activation [27]. Lepirudin has therefore been considered the preferred anticoagulant for whole blood when the role of complement 
activation in vitro is examined [27]. The levels of 27 different cytokines, interleukins and growth factors in EDTA, citrate, heparin and lepirudin plasma and 
serum obtained from ten healthy blood donors were therefore examined. The influence of storage time and temperature before and after centrifugation on 
cytokine levels were also studied.  
6 
 
2. Materials and methods 
2.1 Study population 
To examine the effects of temperature and storage time on cytokine levels, venous blood was collected from ten healthy blood donors (five females and five 
males). The donors were without any medication and did not experience fever or and other symptoms of infectious or inflammatory illness during the two 
weeks prior to blood sampling. The blood donors provided written informed consent. The study was approved by the regional ethics committee of the northern 
Health Region of Norway. To determine the reference ranges, EDTA plasma samples from the following groups of healthy donors were included: 1) 49 healthy 
blood donors from the Blood Bank of Nordlandssykehuset Bodø, 2) 42 healthy controls in a clinical epidemiological study performed in Nordland County, 
Norway, 3) and 4) 71 heathy persons from a local study on health care workers. ; giving a total of 162 healthy Norwegian persons (107 females and 55 males, 
aged range 18-85).  The samples were obtained by venipuncture after an overnight fast, between 8 and 9 a.m. and were immediately placed on ice, centrifuged 
within 15 min at +4°C and stored at -80°C until analysis.  
2.2 Blood sampling and sample tubes 
To prevent contamination by tissue thromboplastin during sampling, blood was first drawn into one dry 5-mL Vacutainer® tube (Becton Dickinson (BD), 
Plymouth, UK), which was discarded. Winged blood collection sets (BD Vactuainer® Safety-Lok™, needle gauge 21, needle length 0.75 inches, tubing length 
7 inches, with luer locks (Franklin Lakes, NJ, U.S.A.) were used to collect the blood. Tubes were filled in the following order: blood collected in lepirudin-
containing tubes (Refludan®, 50 μg/mL) was added to 4.5-mL Nunc™ polypropylene CryoTubes™ (NUNC A/S, Roskilde, Denmark) using lids from dry 4.5-
mL BD Vacutainer® tubes, blood for serum samples was collected in tubes without an additive (Vacuette®, 2 mL), in 3.2% sodium citrate Vacuette® tubes (2 
mL), in lithium heparin tubes (Vacuette®, 4 mL), in K3EDTA tubes (Vacuette®, 2 mL), and in serum sep clot activator tubes (Vacuette®, 4 mL). All 
Vacuette® tubes were purchased from Greiner Bio-One GmbH (Kremsmünster, Austria). All of the tubes were held vertically during sampling to prevent 
contamination by anticoagulants between using the different tubes. All tubes were gently rotated eight times by hand after sampling.  
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2.3 Whole blood storage conditions 
After the blood samples were collected, one tube (T0) was immediately centrifuged at 3220 x g for 15 min at 4°C and stored at -80°C. Two tubes were stored at 
+4°C and two tubes were stored at room temperature (RT), one for one hour (T1h) and one for four h (T4h). In the case of the two serum sampling tubes, the 
same procedure was initiated after one h of coagulation at room temperature. 
 
2.4 Treatment of plasma samples 
Four blood donors were selected using the same exclusion criteria applied in the first experiment and using the same blood sampling technique. We chose four 
different plasma collection tubes, as follows: 1) lepirudin-containing tubes, to which EDTA was added immediately before centrifugation to prevent further 
complement activation, 2) citrate-containing tubes (3.2% sodium citrate), 3) EDTA-containing tubes (4.43 mM final concentration) and 4) EDTA containing 
tubes (10 mM final concentration).  
To obtain higher levels of cytokines for testing cytokine stability, some of the lepirudin anticoagulated whole blood samples were incubated with E. coli (1 x 
107/mL) in Nunc™ cryotubes. The tubes were incubated for 2 h at 37°C before centrifugation. Control samples were obtained by immediate centrifugation 
(T0p). To examine the stability of cytokines in the plasma samples, the samples were stored in Nunc tubes in the dark at either room temperature (RT) or at 
+4°C for two, four and 24 h. The E. coli strain LE392 (ATCC 33572) was obtained from American Type Culture Collection (Manassas, VA, U.S.A.). E. coli 
was grown overnight on a lactose dish, after which 5-10 colonies were transferred to LB-medium (1% tryptone, 0.5% (w/v) yeast extract, 1% (v/v) NaCl) 
purchased from Becton Dickinson (Sparks, MD) and grown overnight. The bacteria were harvested and washed once with Dulbecco’s PBS without Ca2+ and 
Mg2+ by centrifugation at 3220 x g for 10 min at 4°C. The bacteria were aliquoted, heat inactivated for 1 h at 60°C and stored at -80°C. A frozen ampoule was 
thawed at ambient temperature and the cells were washed six times with PBS by centrifugation at 3220 x g for 10 min at 4°C. 
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2.5 Freezing and thawing of plasma 
The effect of freezing and thawing on the cytokines was examined using the T0p plasma samples (the lepirudin, sodium citrate, 4.43 mM and 10 mM EDTA 
samples) The samples were frozen (-80°C) and then thawed on ice (0°C) for 20 min, followed by one h of storage on ice to simulate standard sample handling. 
The samples were then maintained in a  
-80°C freezer for a minimum of 2 h to ensure freezing. The samples were then frozen and thawed 1, 3 and 6 times. 
 
2.6 Cytokine analyses 
The cytokines in the plasma and serum samples were analysed using a Bio-Plex Human Cytokine 27-Plex Panel kit purchased from Bio-Rad Laboratories Inc. 
(Hercules, CA, U.S.A.). The analyses was performed using high-sensitivity detection according to the manufacturer`s instructions. Estimated values below the 
lowest standard were used. The following cytokines were analysed: interleukin (IL)-1 beta (IL-1β), IL-1 receptor antagonist (IL-1Ra), IL-2, IL-4, IL-5, IL-6, 
IL-7, IL-8 (C-X-C motif chemokine ligand 8; CXCL8), IL-9, IL-10, IL-12, IL-13, IL-15, IL-17, eotaxin-1 (C-C motif ligand 11; CCL11), basic fibroblast 
growth factor (FGF basic), granulocyte colony stimulating factor (G-CSF), granulocyte-macrophage colony stimulating factor (GM-CSF), interferon gamma 
(IFN-γ), IP-10, monocyte chemoattractant protein 1 (MCP-1 or CCL2), macrophage inflammatory protein-1-alpha (MIP-1α or CCL3), macrophage 
inflammatory protein-1-beta (MIP-1β or CCL4), platelet-derived growth factor-BB (PDGF-BB), RANTES (CCL5), tumour necrosis factor (TNF) and vascular 
endothelial growth factor (VEGF).  
 
2.7 Statistical analyses  
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GraphPad Prism 5 (GraphPad Software, CA) was used for the statistical calculations. A non-parametric, one-way repeated measurement ANOVA with Dunn’s 
post-test was used to compare the pre-analytical sampling conditions. To analyse the effects of whole blood incubation, all of the T0 samples were compared to 
the T0 tube with the highest median concentration, which was the control. The dilution of the plasma due to the volume of citrate added to the citrate-containing 
tubes was corrected for and each donor’s haematocrit was corrected according to the method of Van Beaumont [28]. The data regarding storage of whole blood 
and plasma at different temperatures (4°C and RT) in each type of sample tube were analysed separately, leaving time as the only variable, by comparing the 
T1h and T4h samples to the T0 sample in the same series. P<0.05 was considered to indicate significant differences. The Excel program (Microsoft Corp., 
Redmond, WA) replaced immeasurable cytokine levels with random numbers between 0.001 and the lower detection limit value. Measurable cytokine levels 
that were lower than that of LDL were accepted as valid numbers. Some of the levels of the cytokine RANTES were greater than the highest detection limit 
(HDL). Excel replaced these values with random numbers between the level of HDL and the highest measured concentration of RANTES that we measured. 
The data for the MIP-1β, IL-1β and IP-10 levels included one extreme outlier that exceeded the mean value +/- 3 SD of the other data, which were therefore 
excluded from the T0 figures without affecting the results of the statistical analyses. The distribution of cytokines in females and males were compared using 
Mann-Whitney U-test.   
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3. Results 
We first aimed to investigate the optimal conditions for sampling, handling and storage of samples to be analysed for the 27 cytokines. Ten blood donors were 
selected for these experiments.   
3.1 Effect of plasma anticoagulants on cytokine levels in immediately cooled and centrifuged blood samples compared with serum samples  
The cytokine levels in EDTA, citrate, lepirudin and heparin-plasma obtained from immediately cooled and centrifuged blood samples and compared them with 
the levels in serum samples were studied. Two different serum-collection tubes were used, one was a plain tube lacking a gel and the other contained a gel and a 
clot activator. Of the 27 cytokines analysed, all were detected above the lower detection limit in > 25% (see below for details). . Twelve of these were 
representative for the group and are presented in detail (Figures 1 and 2). In general serum samples showed substantionaly and significantly (P<0.05) higher 
levels than plasma samples (Figure 1),  , whereas IP-10 and MCP-1 did not show these major difference between plasma and serum (Figure 2). Notable, two of 
the cytokines, MIP1-β and MCP-1, were markedly and significantly increased in heparin plasma (Figure 2).  Two of the cytokines, RANTES and PDGF-BB, 
were markedly higher in serum than in plasma samples (Figure 1), consistent with in vitro release during coagulation.  
 
Upon correcting for the time during which the serum samples coagulated at RT, reached by comparing the T0 serum with plasma that had been stored at RT for 
1 h, it was found that the differences in all of the cytokine levels, except for those of IL-5 and MIP-1α, were significant.  
 
All together,  these results indicate that cytokines should be analysed in EDTA blood samples, immediately cooled and rapidly centrifuged to obtain EDTA 
plasma to be stored.   
  
3.2 Effect of storage time and temperature of whole blood samples upon plasma separation for detection of cytokine levels 
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The effect of storage time and temperature on the cytokine levels in EDTA-, citrate- and lepirudin-anticoagulated whole blood was investigated (Table 1). The 
here listed 15 cytokines were selected  based on their robust measurable  amount in the samples from tubes that were stored for 1 and 4 h at RT or 4°C. Stable 
cytokine levels were observed in whole blood anticoagulated with EDTA, citrate and lepirudin when the samples were stored at 4°C for one h. However, when 
EDTA-, citrate- or lepirudin-anticoagulated whole blood was stored at RT, a significant increase in some of cytokine levels were observed after only one h of 
storage (Table 1). An even more pronounced increase in the levels of several cytokines was observed after 4 h of incubation at RT, indication  an in vitro 
cytokine release during storage at RT.  
 
 
3.3 Effect on the cytokines of temperature. 
We next examined the stability of the cytokines in plasma during storage. Plasma obtained from E. coli-incubated whole blood contained high levels of 13 
different cytokines (Table 2). The cytokine levels were stable for up to four h at 4°C in the lepirudin- and EDTA-plasma, but after 24 h, the levels of some of 
the cytokines decreased. Upon incubation at RT, a decrease in some of the cytokine levels was observed after only 4 h and the levels of some cytokines even 
increased with increasing incubation time.  The highest concentration of EDTA examined (10 mM) did not influence the stability of any of the cytokines in 
plasma . The results indicate that EDTA plasma samples can be stored for up to 4 h at 4°C after centrifugation and before freezing.  
 
3.4 The effect of freezing and thawing on plasma cytokine levels 
The effect of freezing and thawing on cytokine stability were then examined in EDTA and citrate plasma (Table 3). There was no significant change in the 
cytokine levels in plasma frozen and thawed up to three times. After freezing and thawing 6 times, a slight but significant decrease in the IL-1β and RANTES 
levels was observed in EDTA plasma, suggesting a maximum of three freezing and thawing in the recommendations.  
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We second aimed to define a reference range in a healthy human population. Based upon the above findings, we decided to test EDTA plasma, immediately 
stored cold, centrifuged within one h and stored at -80°C.       
3.5 Reference ranges of the cytokine levels in EDTA plasma obtained from 162 healthy controls 
The reference ranges for the cytokines in EDTA plasma obtained from 162 healthy blood donors were then established (Table 4). Both the 2.5-97.5th percentile 
and the < 95th percentile levels of the cytokines are shown. Some of the cytokines were detected in samples obtained from all of the blood donors, implying that 
both the 2.5-97.5th percentile values could be calculated. The frequency distribution of these cytokines indicated that the upper limit was similar in females and 
males (Figure 3, Table 4, Supplementary Table 1, and supplementary Figure 1). However, The frequency distribution and statistical analyses of these 27 
biomarkers indicated that none of these inflammatory biomarkers were normally distributed (Supplementary Figure  The number of individuals (%) with 
detectable cytokines (n) were: >75%: n=16; 50-75%: n=6; 25-50%: n=5; <25%=n=0.    
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4. Discussion 
 
The findings of this study indicate that the sampling conditions greatly affect the cytokine levels. In general, serum showed considerably higher levels in 
samples taken from both types of serum collection tubes as compared with those in plasma. After centrifugation and separation, the cytokine levels were stable 
in plasma samples. In contrast, storage of whole blood samples, particularly when the latter were stored at room temperature, lead to increase in many of the 
cytokines, consistent with in vitro release from the cells. EDTA-plasma, obtained from blood stored on slushed ice < one h, consistently contained the lowest 
levels for the cytokines and could be recommended as guidelines for sampling.  Thus, the tentative reference ranges for the cytokines were calculated using 
EDTA plasma obtained according to these guidelines from samples obtained from 162 healthy controls.  
 
The higher cytokine levels observed in serum compared with those in plasma suggest that the coagulation process and thrombin activation enhances cytokine 
release. This result is consistent with those of previous studies [29, 30]. The cytokine levels in samples taken from both types of serum collection tubes after 
one h of coagulation at RT were significantly higher than the levels in the baseline anticoagulated samples (T0) and anticoagulated whole blood that was stored 
for one h at RT. When the levels of the soluble terminal complement complex (sTCC) as a measure of complement activation were analysed using an ELISA, 
we found that complement was activated only in the serum collection tube containing a gel (data not shown). This result indicates that complement activation is 
not responsible for the high concentration of cytokines in serum. Thus, we suggest that coagulation itself induce cytokine release from whole blood leukocytes. 
This hypothesis is in accordance with a previous observation that thrombin activates leukocytes and cytokine release through the activation of PAR-1 and PAR-
4 [31].  
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In anticoagulated whole blood, the levels of many cytokines were increased when the samples were stored at RT, even in the presence of EDTA. These results 
are likely due to the in vitro synthesis or release of pre-synthesized cytokines by leukocytes  EDTA itself [32], a process that is prevented at low temperature. 
Interestingly, in the lepirudin-anticoagulated whole blood in which thrombin activity was specifically inhibited, only a small increase in the release of PDGF-
BB, IL-2, IL-4 and IL-5 was observed, indicating that thrombin is involved in the release of these cytokines. Further studies are needed to explain these 
findings. Due to the temperature effect,  we recommend that whole blood samples be placed on ice (0°C) after collection and be immediately centrifuged. If 
centrifugation is delayed, we recommend storage for up to one h and a maximal storage of 4 h at +4°C before centrifugation.  
 
The use of heparin plasma should be avoided because the levels of several cytokines, in particular MIP-1β and MCP-1, were elevated in such samples. While 
the reason for this phenomenon remains to be elucidated, we speculate that heparin may activate monocytes and cytokine release in whole blood, as indicated in 
a previous report [33]. Furthermore, heparin and citrate, in contrast to EDTA, significantly affected the upregulation of tissue factor and platelet activation in 
fresh human whole blood [34]. This result supports the observation that the anticoagulant used significantly affects coagulation, platelet activation, and the 
cytokine levels in fresh human whole blood and it is reasonable to suggest that among the available anticoagulants, EDTA is the one to be preferred for 
cytokine analysis.   
 
The levels of cytokines in plasma were more stable than were those in whole blood. Therefore, plasma should be separated from the cellular fraction optimally 
within one h and maximally four h after blood sampling, After separation of plasma, the  cytokines were relatively stable although time and temperature 
influenced the levels. Storage at RT for up to 24 hours lead to a decrease in some cytokines and increase in others. A decrease may be related to the lower level 
of stability of some cytokines in plasma, their degradation by proteases or the binding of the cytokines to their respective soluble cellular receptors. Changes in 
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this binding over time could also possibly explain the changes in cytokine levels that occur during sample storage. Notably, none of the cytokines changed 
during storage of EDTA plasma for up to 4 hours at 4°C. 
 
Finally, the reference ranges of the cytokines in 162 healthy controls were estimated using the upper 95th percentile and the 2.5-97.5th percentile values from 
EDTA plasma samples, obtained in the morning and treated according to the condition described above.  We suggest the upper 95th percentile values to be the 
best estimate of the reference range instead of 2.5th and 97.5th for two reasons. First, from a pathophysiological point of view an increased value of a cytokine 
would be more frequent and reflect a disease state than a low value. Second, for most of the cytokines there were some individuals with undetectable levels, 
precluding an exact 2.5th percentile to be calculated. Although the distribution of cytokine values were statistically different in males and females for eight of 
the cytokines, most of them had very similar upper 95th percentile values. Thus, the significant difference was due to a different distribution pattern, not 
influencing the 95th percentile. We therefore suggest that a common reference range can be used for males and females.  
In conclusion, our data indicate that the cytokine levels in several plasma samples, including EDTA plasma samples, are significantly lower than those in 
serum. Previeous studies using serum should be interpreted with some caution. The mechanisms underlying the greater cytokine levels in serum compared with 
those in plasma remain to be elucidated, but this study indicates that thrombin-induced cytokine release might be involved. Recommended guidelines for 
cytokine analyses based on our data would be: EDTA blood immediately cooled on crushed ice, centrifuged within one h, plasma stored maximum 4 h at 4°C 
and stored at -80°C.  The samples can be thawed and frozen up to three times.    
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Figure legends 
 
Figure 1.  
Cytokine levels in serum compared with those in immediately centrifuged and frozen EDTA, citrate, lepirudin and heparin plasma samples. The levels 
of (a) IL-1β, (b) IL-1ra, (c) IL-6, (d) IL-8 or C-X-C motif chemokine ligand 8, (e) TNF, (f) IL-17, (g) RANTES and (h) PDGF-BB were analysed using 
Multiplex technology and expressed as pg/mL on the Y axis. The data are given as median values with whiskers (10 and 90 percentiles, n=10). Serum +; serum 
tubes containing a gel and a clot activator. *P<0.05 compared with the tube in which the highest median concentration of cytokine was detected (H). #P<0.05 
compared with that detected in the tube with lowest median cytokine concentration (L).  
 
Figure 2.  
Cytokines detected at similar levels in serum and the immediately centrifuged and frozen EDTA, citrate, lepirudin and heparin plasma samples (a, b), 
and those who were elevated in heparin plasma (c,d). The levels of (a) Eotaxin-1, (b) IP-10, (c) MCP-1 and (b) MIP-1β were analysed using Multiplex 
technology and expressed as pg/mL on the Y axis. The data are given as median values with whiskers (10 and 90 percentiles, n=10). Serum +: serum tubes 
containing a gel and a clot activator. *P<0.05 compared with the tube in which the highest median concentration of cytokine was detected (H). #P<0.05 
compared with that detected in the tube with lowest median cytokine concentration (L)  
 
 
 
Figure 3.  
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Figure 3.  
Frequency histograms of selected cytokines in 162 healthy individuals. (a) Interleukin (IL)-1β, (b) IL-5, (c) C-X-C motif chemokine ligand 8 or 
CXCL8, (d) C-C motif ligand 2 or CCL2, (e) CCL3, (f) CCL4, (g) GM-CSF and (h) CXCL10 were measured using a multiplex cytokine assay. The 
histogram contains grey bar graphs showing the frequency distribution of the cytokines. On the x-axis is the value of the cytokine in pg/mL. On the y-axis 
is the number of persons with these values. The data were analyzed using the Prism 6 for Mac OS X. 
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Legends to supplementary figure 1: 
 
Suppl. Figure 1.  
Frequency histograms of some cytokines from 107 females (grey bars) and 55 males (black bars). (a) Interleukin (IL)-1β, (b) IL-%, (c)  C-X-C motif 
chemokine ligand 8 or CXCL8, (d) CCL2, (e) CCL3, (f) CCL4, (g) GM-CSF and (h) CXCL10 were measured using a multiplex cytokine assay. The 
histogram contains grey bar graphs showing the frequency distribution of the cytokines. On the x-axis is the value of the cytokine in pg/mL. On the y-axis 
is the number of persons with these values. The data were analyzed using the Prism 6 for Mac OS X. 
 
Table 1. Cytokine levels in plasma obtained from whole blood containing different anticoagulants that was stored at 4°C and room temperature before centrifugation.  
Cytokinea  EDTAb  Citrateb  Lepirudinb 
 
 4°C RTc  4°C RTc  4°C RTc 
 
 T1hd T4hd T1hd T4hd  T1hd T4hd T1hd T4hd  T1hd T4hd T1hd T4hd 
 IL-1β   0.84 
(0.28-2.87) 
1.1 
(0.3-22) 
3.8* 
(1.2-32) 
5.1*  
(1.2-73) 
 1.0  
(0.9-2.3) 
1.2  
(0.9-15) 
1.4*  
(1.2-12) 
1.7* 
(1.1-13) 
 1.1  
(0.7-3.0) 
1.6  
(0.5-2.2) 
1.8* 
(1.1-3.0) 
1.9*  
(1.0-4.3) 
 IL-1ra   0.8 
(0.4-4.8) 
1.4 
(0.3-4.4) 
6.6* 
(3.8-96) 
16* 
(1.8-215) 
 1.0 
(0.3-2.7) 
1.17 
(0.36-2.17) 
2.0* 
(1.5-5.9) 
3.9* 
(0.6-29) 
 1.1 
(0.2-73) 
1.1 
(0.8-29) 
2.8* 
(1.4-106) 
3.2* 
(1.1-180) 
 IL-4   1.0 
(0.2-2.2) 
1.0 
(0.04-121) 
54* 
(2.1-257) 
50* 
(1.2-392) 
 1.7 
(1.0-26) 
1.7* 
(1.0-97) 
57* 
(1.9-87) 
29* 
(1.0-128) 
 1.4 
(0.8-25) 
2.0 
(0.7-15) 
3.1* 
(1.8-24) 
3.6* 
(1.1-27) 
 IL-5   1.2 
(0.8-3.8) 
0.9 
(0.5-66) 
9.6* 
(2.5-210) 
12* 
(1.2-344) 
 1.0 
(0.8-1.6) 
0.9 
(0.1-96) 
1.7 
(1.0-43) 
2.1* 
(1.0-19) 
 1.4 
(0.5-4.8) 
1.3 
(0.4-61) 
2.7* 
(1.5-20) 
3.1* 
(1.2-25) 
 IL-6   1.0 
(0.5-3.9) 
1.2 
(0.14-4.0) 
6.5 
(1.5-210) 
11* 
(0.9-290) 
 1.0 
(0.8-2.3) 
1.1 
(0.6-1.8) 
2.7* 
(1.4-4.8) 
2.5* 
(0.9-5.8) 
 1.0 
(0.5-3.4) 
1.5 
(0.3-3.1) 
1.8* 
(0.8-4.1) 
1.8 
(0.4-3.3) 
 IL-7   1.0 
(0.07-2.7) 
1.2 
(0.1-7.9) 
18 
(0.8-33) 
27* 
(2.1-131) 
 1.3 
(0.08-3.1) 
0.9 
(0.08-3.0) 
1.6 
(0.8-22) 
1.2 
(0.9-6.5) 
 1.7* 
(0.5-34) 
1.5 
(0.2-29) 
3.3 
(1.0-75) 
2.1 
(0.6-31) 
 IL-8   0.7 
(0.08-12) 
0.9 
(0.05-20) 
7.6 
(0.4-121) 
11* 
(0.36-189) 
 1.1 
(0.1-28) 
0.8 
(0.01-2.5) 
1.9 
(0.5-23) 
1.2 
(0.03-39) 
 1.2 
(0.5-50) 
1.0 
(0.24-1.9) 
4.1* 
(1.0-99) 
1.5 
(0.6-132) 
 IL-9   0.8 
(0.08-1.4) 
1.1 
(0.08-3.3) 
5.1 
(0.17-225) 
21 
(0.17->1000) 
 1.0 
(0.6-4.0) 
1.0 
(0.02-4.3) 
2.1 
(0.5-9.6) 
2.1 
(0.7-39) 
 1.4 
(0.3-171) 
1.1 
(0.5-22) 
2.6* 
(0.9-323) 
2.4 
(0.8-144) 
 IL-13   1.1 
(0.18-2.1) 
1.1 
(0.34-9.8) 
3.7 
(0.7-126) 
12* 
(1.3-380) 
 1.4 
(0.09-27) 
0.8 
(0.02-2.8) 
1.9 
(0.06-29) 
1.1 
(0.08-19) 
 0.34 
(0.12-4.3) 
0.6 
(0.06-3.4) 
1.5 
(0.1-3.4) 
1.2 
(0.06-38) 
 CCL11   0.8* 
(0.7-1.1) 
0.9 
(0.7-1.2) 
1.3 
(0.8-1.7) 
1.5* 
(1.0-2.1) 
 0.9* 
(0.8-1.1) 
0.9 
(0.6-1.5) 
0.9 
(0.7-1.1) 
0.9 
(0.6-1.3) 
 0.7 
(0.5-1.4) 
0.7* 
(0.3-1.4) 
0.9 
(0.6-2.2) 
0.7 
(0.5-1.7) 
 G-CSF   1.0 1.0 6.9* 7.0*  1.1 1.0 7.4* 3.7*  1.7 1.47 2.8* 2.5 
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(0.01-1.3) (0.06-15) (1.4-465) (2.0-787) (0.6-36) (0.9-21) (1.3-362) (0.7-432) (0.5-483) (0.36-257) (0.9-586) (0.4-265) 
 CXCL10   1.0 
(0.9-1.2) 
1.1 
(0.8-1.4) 
1.0 
(0.8-1.3) 
0.9 
(0.8-1.1) 
 0.9 
(0.8-1.2) 
0.9 
(0.7-1.2) 
0.8 
(0.8-1.6) 
0.8 
(0.5-2.0) 
 0.9 
(0.8-1.2) 
0.9* 
(0.8-1.1) 
0.9 
(0.8-1.3) 
0.8 
(0.6-1.0) 
 CCL2   0.8 
(0.5-2.8) 
0.9 
(0.3-1.1) 
0.6 
(0.4-2.9) 
0.4* 
(0.13-2.9) 
 0.9 
(0.6-2.3) 
0.8 
(0.14-1.2) 
0.7* 
(0.1-0.9) 
0.36* 
(0.1-0.7) 
 0.8 
(0.03-1.1) 
0.5* 
(0.04-1.2) 
0.8 
(0.35-1.3) 
0.6* 
(0.02-0.9) 
 PDGF-BB   1.7 
(0.36-18) 
2.6 
(0.05->1000) 
743 
(3.6->1000) 
760* 
(1.7->1000) 
 4.1 
(0.3-506) 
6.1* 
(1.8->1000) 
84* 
(3.9->1000) 
203* 
(2.3->1000) 
 2.8 
(0.4-13) 
4.4 
(0.13-11) 
7.3* 
(2.3-30) 
8.1* 
(1.4-42) 
 CCL5   1.2 
(0.7-2.1) 
0.9 
(0.1-70) 
16* 
(1.3-92) 
14* 
(1.5-206) 
 4.0* 
(2.1-10) 
5.9* 
(1.2-83) 
20* 
(2.3-75) 
18* 
(2.19-241) 
 2.4 
(0.7-5.3) 
2.8 
(0.4-3.8) 
3.3* 
(1.1-8.5) 
1.5 
(0.6-3.5) 
 
a The cytokine levels are given as the median fold change (10-90 percentile) of their respective T0 values.  
b The effect on cytokine levels of storing EDTA-, citrate- and lepirudin-anticoagulated whole blood at 4°C and room temperature for one and four h. One sample of each anticoagulant was immediately centrifuged and stored at -80°C. Two 
samples containing each anticoagulant were stored at 4°C and two samples were stored at room temperature, one for one h and one for four h.  
c RT= room temperature. 
d T1h: one h of storage before centrifugation. T4h: four h of storage before centrifugation.  
*P<0.05 compared to its respective T0 basal sample.  
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Table 2. Stability of cytokines in plasma obtained from E. coli-stimulated whole blood stored at 4°C or room temperature after centrifugation. 
Cytokinea  EDTAb  Citrateb 
   4°C RTc   4°C RTc 
  T2hd T4hd T24hd T2hd T4hd T24hd  T2hd T4hd T24hd T2hd T4hd T24hd 
IL-1β 
 
1.0 
(0.9-1.2) 
0.9 
(0.7-0.9) 
0.7* 
(0.6-1.0) 
1.0 
(0.9-1.1) 
0.9 
(0.8-1.0) 
0.9 
(0.8-1.0) 
 
1.1 
(0.9-1.2) 
1.0 
(0.8-1.1) 
0.8 
(0.6-0.9) 
1.1 
(0.9-1.2) 
1.0 
(0.8-1.2) 
0.8* 
(0.6-0.9) 
IL-1ra 
 
1.3 
(1.0-1.6) 
0.7 
(0.6-0.8) 
0.6 
(0.4-1.5) 
1.0 
(0.9-1.1) 
0.8 
(0.7-0.9) 
0.7 
(0.6-1.0) 
 
1.0 
(0.7-1.3) 
0.9 
(0.8-1.2) 
0.8 
(0.6-1.1) 
1.1 
(0.6-1.4) 
0.9 
(0.8-0.9) 
0.8 
(0.6-0.9) 
IL-6 
 
1.1 
(1.1-1.3) 
1.0 
(0.8-1.1) 
1.1 
(0.9-1.2) 
1.1 
(1.0-1.2) 
1.0 
(0.9-1.2) 
1.0 
(0.9-1.1) 
 
1.1 
(1.0-1.2) 
1.1 
(1.0-1.2) 
1.2 
(1.0-1.4) 
1.2 
(0.9-1.4) 
1.1 
(1.1-1.2) 
1.1 
(1.0-1.1) 
IL-8 
 
1.1 
(1.0-1.8) 
0.9 
(0.6-1.0) 
0.7 
(0.3-0.9) 
1.1 
(0.9-1.2) 
0.8 
(0.5-1.1) 
1.1 
(0.8-1.4) 
 
1.1 
(1.0-1.1) 
1.1 
(1.0-1.2) 
1.1 
(0.9-1.2) 
1.2 
(1.0-1.4) 
1.1 
(1.1-1.2) 
1.0 
(0.9-1.2) 
IL-9 
 
1.2 
(0.8-1.5) 
0.6 
(0.5-1.1) 
0.8 
(0.7-1.2) 
0.8 
(0.6-1.1) 
0.7 
(0.44-1.2) 
0.8 
(0.7-1.0) 
 
1.2 
(1.0-1.2) 
0.9 
(0.8-1.1) 
0.8 
(0.55-0.9) 
0.9 
(0.8-1.3) 
0.9 
(0.8-1.2) 
0.8 
(0.8-0.9) 
CCL11 
 
0.9 
(0.5-1.1) 
0.7 
(0.6-0.9) 
0.9 
(0.8-1.1) 
0.9 
(0.5-1.0) 
0.8* 
(0.4-1.0) 
0.9 
(0.8-1.0) 
 
1.2 
(1.0-1.3) 
1.0 
(0.8-1.2) 
0.9 
(0.8-1.1) 
1.0 
(0.9-1.3) 
0.9 
(0.9-1.1) 
0.9 
(0.8-1.0) 
IFN-γ 
 
0.8 
(0.7-1.8) 
0.8 
(0.45-1.3) 
0.9 
(0.6-1.3) 
0.9 
(0.6-1.3) 
0.7 
(0.5-1.3) 
1.0 
(0.9-1.2) 
 
1.0 
(1.0-1.2) 
0.9 
(0.8-1.1) 
0.8 
(0.6-1.1) 
0.9 
(0.7-1.2) 
0.8 
(0.7-1.1) 
0.7* 
(0.7- 0.8) 
CXCL10 
 
1.0 
(0.8-1.2) 
0.9 
(0.8-1.1) 
1.0 
(0.9-1.9) 
1.0 
(0.9-1.0) 
0.8 
(0.7-1.0) 
1.1 
(0.9-1.2) 
 
1.0 
(1.0-1.1) 
1.0 
(0.8-1.1) 
0.9 
(0.8-1.1) 
0.9 
(0.9-1.2) 
0.9 
(0.8-1.0) 
0.8* 
(0.7-0.9) 
CCL3 
 
1.0 
(0.9-1.4) 
1.0 
(0.8-1.3) 
1.1 
(0.9-1.5) 
1.0 
(0.9-1.2) 
1.0 
(0.8-1.2) 
1.2 
(1.0-1.4) 
 
1.1* 
(1.1-1.2) 
1.0 
(1.0-1.2) 
1.1 
(0.8-1.1) 
1.1 
(1.0-1.3) 
1.0 
(1.0-1.2) 
1.0 
(0.8-1.1) 
CCL4 
 
1.1 
(1.0-1.2) 
1.0 
(0.9-1.1) 
1.1 
(0.9-1.2) 
1.2 
(1.1-1.2) 
1.1 
(1.0-1.2) 
1.3* 
(1.2-1.5) 
 
1.3 
(0.7-1.6) 
1.1 
(0.8-1.7) 
1.1 
(0.7-1.7) 
1.3 
(0.8-1.6) 
1.2 
(1.0-1.3) 
1.2 
(0.9-1.4) 
PDGF-BB 
 
1.0 
(0.7-1.1) 
0.9 
(0.8-1.0) 
1.0 
(0.5-1.3) 
1.0 
(0.8-1.2) 
0.7 
(0.6-1.1) 
1.1 
(0.9-1.1) 
 
1.2* 
(1.2-1.3) 
1.2 
(0.8-1.2) 
1.0 
(1.0-1.2) 
1.1 
(1.0-1.3) 
1.0 
(0.9-1.3) 
1.1 
(1.1-1.1) 
CCL5 
 
1.1 
(1.1-1.1) 
1.0 
(0.9-1.1) 
1.1 
(1.0-1.3) 
1.3 
(1.1-1.4) 
1.1 
(1.1-1.5) 
1.3* 
(1.2-1.9) 
 
1.2 
(0.9-1.3) 
1.2 
(1.0-1.3) 
1.4* 
(1.0-1.4) 
1.4 
(1.0-1.4) 
1.2 
(1.1-1.7) 
1.3 
(1.2-2.2) 
TNF 
 
1.0 
(0.9-1.2) 
0.8 
(0.7-1.1) 
0.7 
(0.6-1.0) 
1.0 
(0.8-1.2) 
0.8 
(0.6-1.2) 
0.9 
(0.6-1.0) 
 
1.0 
(1.0-1.1) 
1.0 
(0.9-1.3) 
1.0 
(0.7-1.3) 
1.2 
(0.8-1.4) 
1.0 
(1.0-1.0) 
0.7 
(0.7-1.0) 
 
a The cytokine levels are given as the median fold change (10-90 percentiles) of their respective T0 values.  
b The effect on cytokine levels of storing EDTA-, citrate- and lepirudin-anticoagulated whole blood at 4°C and room temperature for one and four h. One sample of each anticoagulant was immediately centrifuged and stored at -80°C. Two 
samples containing each anticoagulant were stored at 4°C and two samples were stored at room temperature, one for one h and one for four h.  
c RT= room temperature. 
d T1h: one h of storage before centrifugation. T4h: four h of storage before centrifugation.  
*P<0.05 compared to its respective T0 basal sample.  
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Table 3. The effect of freezing and thawing on cytokine stability 
Cytokinea  EDTAb  Citrateb 
 
 3 timesc 6 timesc  3 timesc 6 timesc 
 IL-1β   0.9 
(0.9-0.9) 
0.8* 
(0.7-0.8) 
 1.0 
(0.9-1.0) 
0.9 
(0.8-1.1) 
 IL-1ra   1.1 
(0.9-1.1) 
0.9 
(0.9-1.0) 
 1.0 
(0.9-1.1) 
0.9 
(0.8-1.2) 
 IL-6   1.0 
(1.0-1.1) 
1.0 
(1.0-1.1) 
 1.0 
(0.9-1.1) 
1.0 
(0.9-1.3) 
 IL-8   1.1 
(0.9-1.2) 
1.0 
(1.0-1.0) 
 1.0 
(0.9-1.1) 
1.1 
(0.9-1.3) 
 IL-9   1.1 
(0.7-1.5) 
1.0 
(1.0-1.2) 
 1.1 
(0.8-1.1) 
0.9 
(0.8-1.1) 
 CCL11   1.1 
(0.9-1.2) 
1.1 
(1.0-1.2) 
 1.0 
(1.0-1.1) 
1.1 
(0.8-1.1) 
 IFN-γ   1.0 
(1.0-1.6) 
1.0 
(0.6-1.6) 
 0.9 
(0.9-1.1) 
0.9 
(0.8-1.0) 
 CXCL10   0.9 
(0.8-1.0) 
0.9 
(0.8-1.0) 
 1.0 
(0.9-1.2) 
1.0 
(0.8-1.2) 
 CCL3   1.1 
(1.0-1.2) 
1.0 
(0.9-1.0) 
 1.0 
(0.9-1.1) 
1.0 
(0.9-1.2) 
 CCL4   1.3 
(0.8-1.7) 
1.1 
(0.7-1.2) 
 0.9 
(0.4-1.1) 
1.4 
(0.9-2.5) 
 PDGF-BB   1.2 
(0.7-1.2) 
1.0 
(0.8-1.1) 
 1.0 
(0.8-1.2) 
1.0 
(0.8-1.3) 
 RANTES   1.3 
(1.1-1.6) 
1.4* 
(1.4-1.7) 
 1.1 
(1.0-1.2) 
1.4* 
(1.3-1.5) 
 TNF  1.0 
(0.84-1.04) 
1.0 
(0.88-1.02) 
 1.1 
(0.9-1.2) 
0.9 
(0.7-1.1) 
 
a The cytokine levels are given as the median fold change (10-90 percentiles) of their respective T0 values.  
b The effect of freezing and thawing on cytokines in EDTA or citrate plasma.  
c Samples were frozen and thawed three or six times before cytokine analyses.  
*P<0.05 compared to its respective T0 value.  
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Table 4 Reference ranges of cytokines in EDTA plasma 
 Median Reference rangesd 
2.5-97.5 percentiles  
 
<95 perc. 
 
% values 
<LDLe 
 
LDLe 
(pg/mL) 
   
aIL-1β 0.7 0.1-2.0 <1.6 0 0.03 
IL-1RA  26 0-352 <147 5.6 1.2 
IL-2 0 0-10  <7.2 44 0.2 
IL-4 0.5 0-2.0 <1.5 23 0.03 
IL-5 0.7 0-2.2 <1.6 29 0.02 
IL-6 1.5 0-9.3 <5.4 15 0.02 
IL-7 0.5 0-7.6 <6.0 60 0.06 
IL-8 2.8 0-11 <7.9 17 0.01 
IL-9 5.1 0-17  <59 17 0.04 
IL-10 0.0 0-6.6  <3.0 69 0.03 
IL-12(p70)  0.2 0-200  <9.4 63 0.2 
IL-13  1.3 0-11  <5.9 9.3 0.03 
IL-15  0.0 0-2.9 <2.2 46 0.01 
IL-17  0.0 0-69  <31 63 0.01 
MCP-1 (CCL2)b  12.6 3.1-31  <27 0 3.0 
MIP-1α (CCL3)  0.0 0-6 <4.2 77 0.15 
MIP-1β (CCL4)  21 0-63 <50 59 3.9 
RANTES (CCL5)c 824  20-8030 <5379 0 19 
Eotaxin-1 (CCL11)  38 0-120  <91 16 3.8 
FGF basic  0.0 0-51 <40 65 1.0 
G-CSF  5.7 0-47 <43 10 0.37 
GM-CSF  2.0 0-37 <24 33 0.19 
IFN-γ  11.1 0-121 <115 22 1.62 
CXCL10 439 184-1398 <1202 0 159 
TNF  6.4 0-52 <44 27 0.08 
VEGF 0.4 0-12 <6.0 60 0.31 
aIL, interleukin.  
bCCL, chemokine ligand. 
cAll cytokines and biomarkers are expressed as pg/mL.  
dThe cytokine reference ranges were calculated in immediately cooled EDTA plasma samples obtained from 162 healthy individuals.  
eLDL, Lower detection limit, defined as the lowest measurable concentration of each cytokine, including estimated values that were less than that of the lowest standard value.  
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Supplementary Table 1 Female and male reference ranges of cytokines in EDTA plasma 
 Female Male 
 Median Reference 
rangesd 
2.5-97.5 
percentiles 
<95 
perc. 
% values 
<LDLe 
LDLe 
(pg/mL) 
 
Median Reference 
rangesd 
2.5-97.5 
percentiles 
<95 
perc. 
% values 
<LDLe 
LDLe 
(pg/mL) 
 
aIL-1β 0.6 0.1-1.6 <1.4 0  0.9* 0.1-2.0 <2.0 0  
IL-1RA  31 0.0-460 <294 5.6  21 0.0-170 <138 20  
IL-2 0.5 0.0-11 <8.3 44  0.0 0.0-14 <7.3 60  
IL-4 0.4 0.0-2.0 <1.3 23  0.8 0.0-2.0 <2.0 5.5  
IL-5 0.3 0.0-2.5 <1.4 29  0.9* 0.0-3.6 <2.2 7.3  
IL-6 1.7 0.0-9.5 <4.8 15  0.7 0.0-19 <6.2 29  
IL-7 0.0 0.0-8.6 <4.9 60  2.6* 0.0-7.6 <6.8 18  
IL-8 1.6 0.0-13.4 <7.0 17  4.0* 0.0-11 <9.2 7.3  
IL-9 6.1 0.0-163 <58 17  4.0 0.0-560 <154 29  
IL-10 0.0 0.0-4.9 <2.7 69  0.1 0.0-29 <4.4 44  
IL-12(p70) 0.0 0.0-22 <9.3 63  2.1* 0.0-26 <13.5 22  
IL-13  1.1 0-0-8.2 <4.4 9.3  1.4 0.0-34 <8.7 3.6  
IL-15  0.1 0.0-4.4 <2.6 46  0.0 0.0-2.50.0 <1.6 69  
IL-17  0.0 0.0-93 <45 63  0.0 0.0-46 <27 62  
MCP-1 (CCL2)b  13.0 3.1-34 <24 0.9  12.0 1.2-31       <29 1.8  
MIP-1α (CCL3)  0.0 0.0-7.1 <3.6 77  0.0 0.0-9.0 <5.2 58  
MIP-1β (CCL4) 0.0 0.0-57 <47 59  32* 0.0-68 <57 22  
RANTES (CCL5)c 1788 14-11627 <5814 0  370* 49-4558 <4036 0  
Eotaxin-1 (CCL11)  42 0.0-125 <92 19  34 0.0-140 <89 26  
FGF basic  0.0 0.0-52 <27 65  0.0 0.0-63 <43 58  
G-CSF  7.1 0.0-50 <45 10.3  3.2 0.0-53 <37 18  
GM-CSF  2.4 0.0-31 <24 33  0.0 0.0-71 <39 53  
IFN-γ  13.4 0.0-135 <114 22  9.3 0.0-120 <117 33  
CXCL10 455 187-1601 <1250 0  390 169-1647 <1095 0  
TNF  6.9 0.0-54 <46 27  5.5 0.0-51 <42 20  
VEGF 0.0 0.0-11 <5.5 60  1.7* 0.0-16 <9.4 27  
aIL, interleukin.  
bCCL, chemokine ligand. 
cAll cytokines are expressed as pg/mL,  
dThe cytokine reference ranges were calculated in immediately cooled EDTA plasma samples obtained from 107 females and 55 males.  
eLDL, Lower detection limit, defined as the lowest measurable concentration of each cytokine, including estimated values that were less than that of the lowest standard value.  
*P<0.05 when the distribution of cytokine values in females was compared to those in men analysed the using the Mann-Whitney U-test. 
